International variation in and factors associated with hospital readmission after myocardial infarction

JAMA

Volumn 307, Issue 1, 2012, Pages 66-74

  Kociol, Robb D ^a   Lopes, Renato D ^a   Clare, Robert ^a   Thomas, Laine ^a   Mehta, Rajendra H ^a   Kaul, Padma ^b   Pieper, Karen S ^a   Hochman, Judith S ^c   Weaver, W Douglas ^d   Armstrong, Paul W ^b   Granger, Christopher B ^a   Patel, Manesh R ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEXELIZUMAB; PLACEBO;

ADULT; AGED; ARTICLE; AUSTRALIA; CANADA; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE CLASSIFICATION; ELECTROCARDIOGRAPHY; EUROPEAN UNION; FEMALE; GERMANY; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NEW ZEALAND; PERCUTANEOUS CORONARY INTERVENTION; POST HOC ANALYSIS; PRIORITY JOURNAL; REVASCULARIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNITED STATES;

EID: 84855384347     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1926     Document Type: Article

References (25)

1. Lloyd-Jones D, Adams RJ, Brown TM, et al Writing Group Members; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association [published correction appears in Circulation. 2010;121(12):e260]. Circulation. 2010;121(7):e46-e215.
2. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in US deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356(23):2388-2398. (Pubitemid 46883773)
3. Fox CS, Evans JC, Larson MG, Kannel WB, Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation. 2004;110(5):522-527. (Pubitemid 39031167)
4. Capewell S, Morrison CE, McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999;81(4):380-386. (Pubitemid 29167127)
5. Movahed MR, John J, Hashemzadeh M, Jamal MM, Hashemzadeh M. Trends in the age adjusted mortality from acute ST segment elevation myocardial infarction in the United States (1988-2004) based on race, gender, infarct location and comorbidities. Am J Cardiol. 2009;104(8):1030-1034.
6. Rogers WJ, Canto JG, Lambrew CT, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol. 2000;36(7):2056-2063.
7. Krumholz HM, Merrill AR, Schone EM, et al. Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes. 2009;2(5):407-413.
8. Joynt KE, Orav EJ, Jha AK. The association between hospital volume and processes, outcomes, and costs of care for congestive heart failure. Ann Intern Med. 2011;154(2):94-102.
9. Spertus JA, Radford MJ, Every NR, Ellerbeck EF, Peterson ED, Krumholz HM; Acute Myocardial Infarction Working Group of the American Heart Association; American College of Cardiology First Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke. Challenges and opportunities in quantifying the quality of care for acute myocardial infarction. Circulation. 2003;107(12):1681-1691. (Pubitemid 36397340)
10. Desai MM, Stauffer BD, Feringa HH, Schreiner GC. Statistical models and patient predictors of readmission for acute myocardial infarction: a systematic review. Circ Cardiovasc Qual Outcomes. 2009;2(5):500-507.
11. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;50(22):2173-2195. (Pubitemid 350123680)
12. Armstrong PW, Granger CB, Adams PX, et al APEX AMI Investigators. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA. 2007;297(1):43-51.
13. Armstrong PW, Adams PX, Al-Khalidi HR, et al APEX-AMI Steering Committee. Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Am Heart J. 2005;149(3):402-407. (Pubitemid 40585401)
14. Stebbins A, Mehta RH, Armstrong PW, et al Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI Investigators). A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Circ Cardiovasc Interv. 2010;3(5):414-422.
15. Schröder R. Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction. Circulation. 2004;110(21):e506-e510.
16. Brener SJ. Insights into the pathophysiology of ST-elevation myocardial infarction. Am Heart J. 2006;151(6)(suppl):S4-S10. (Pubitemid 43850899)
17. DeWood MA, Spores J, Notske R, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303(16):897-902. (Pubitemid 10021186)
18. Curtis JP, Schreiner G, Wang Y, et al. All-cause readmission and repeat revascularization after percutaneous coronary intervention in a cohort of Medicare patients. J Am Coll Cardiol. 2009;54(10):903-907.
19. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 1997;336(23):1621-1628.
20. Kaul P, Newby LK, Fu Y, et al. International differences in evolution of early discharge after acute myocardial infarction. Lancet. 2004;363(9408):511- 517. (Pubitemid 38229450)
21. Baker DW, Einstadter D, Husak SS, Cebul RD. Trends in postdischarge mortality and readmissions: has length of stay declined too far? Arch Intern Med. 2004;164(5):538-544. (Pubitemid 38314450)
22. Anderson GF, Markovich P. Multinational comparisons of health systems data, 2008. http://www.commonwealthfund.org/~/media/Files/Surveys/2010 /PDF-1371-Anderson-multinational-comparisons-hlt-sys-data-2008-chartbook-v2.pdf. Accessed November 4, 2010.
23. Hernandez AF, Greiner MA, Fonarow GC, et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA. 2010;303(17):1716-1722.
24. Daugherty SL, Ho PM, Spertus JA, et al. Association of early follow-up after acute myocardial infarction with higher rates of medication use. Arch Intern Med. 2008;168(5):485-491. (Pubitemid 351547211)
25. Lau YK, Smith J, Morrison SL, Chamberlain DA. Policy for early discharge after acute myocardial infarction. Br Med J. 1980;280(6230):1489-1492. (Pubitemid 10122467)